about
IHG-1 promotes mitochondrial biogenesis by stabilizing PGC-1α.Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodiesDiabetes mellitus and apoptosis: inflammatory cells.Changes in urinary metabolomic profile during relapsing renal vasculitisIHG-1 amplifies TGF-β1 signalling and mitochondrial biogenesis and is increased in diabetic kidney disease.Diabetic kidney disease and immune modulation.IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses.Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.Urinary Soluble CD163 in Active Renal VasculitisBcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK.Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.BCR-ABL regulates phosphatidylinositol 3-kinase-p110gamma transcription and activation and is required for proliferation and drug resistance.IHG-1 increases mitochondrial fusion and bioenergetic function.Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury.Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.Role of the Immune System in Diabetic Kidney DiseaseAlkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis
P50
Q35142716-35398F4E-4B2D-4E83-98EF-D9B5E9AA1FEAQ35824921-673F317A-A9BE-4A38-885B-20C4A07EBC02Q37440841-38A4C78B-3444-4F46-B383-F150AF484E84Q37460636-31FA0424-7832-4218-9DE5-09BC5B2E689AQ38060966-C04CD826-D0D8-4004-A774-A2CFEF8D8B34Q38110633-075049CC-EFD8-4A41-9678-0DE145DA94C0Q39169336-D1758A45-B047-4892-928B-7DAFD38F386EQ39483786-F0E9F81F-761C-4C67-8275-8848EEF179FAQ39950079-57D54EC0-E827-41E2-A0EB-DF2185FC9EC6Q40429820-34DEC21E-4E3C-48C4-AB69-445386EE79F9Q46653871-4C44993B-06A2-4085-B32E-047BA3588841Q46807683-529F42DB-F08C-489E-8738-E050CFEA679BQ46868599-7E54F81A-0B97-4337-AF89-9315F9F7AD70Q48273241-A666BC9E-69DE-4BB1-9DDE-D109F7503B29Q53174533-D24BC1B6-C4D2-430F-8CCF-E27F28066FA0Q88035415-08EF9102-6B25-46C4-BE24-FA3EFC7310AFQ91207759-6BB69316-4BE8-4C34-8649-E33B1AA3F885
P50
description
researcher ORCID ID = 0000-0002-5855-8010
@en
wetenschapper
@nl
name
Fionnuala B Hickey
@ast
Fionnuala B Hickey
@en
Fionnuala B Hickey
@nl
type
label
Fionnuala B Hickey
@ast
Fionnuala B Hickey
@en
Fionnuala B Hickey
@nl
prefLabel
Fionnuala B Hickey
@ast
Fionnuala B Hickey
@en
Fionnuala B Hickey
@nl
P108
P106
P31
P496
0000-0002-5855-8010